PRND 3′UTR polymorphism may be associated with behavioral disturbances 
in Alzheimer disease

References

• Plassman BL, Langa KM, Fisher GG, Heeringa SG, Weir DR, Ofstedal MB, et al. Prevalence of dementia in the United States: the aging, demographics and memory study. Neuroepidemiology 2007; 29:125 - 132; PMID: 17975326; http://dx.doi.org/10.1159/000109998
   PubMed Web of Science ®Google Scholar
• Fernández M, Gobartt AL, Balañá M. COOPERA Study Group. Behavioural symptoms in patients with Alzheimer's disease and their association with cognitive impairment. BMC Neurol 2010; 10:87; PMID: 20920205; http://dx.doi.org/10.1186/1471-2377-10-87
   PubMed Web of Science ®Google Scholar
• Feldman H, Scheltens P, Scarpini E, Hermann N, Mesenbrink P, Mancione L, et al. Behavioral symptoms in mild cognitive impairment. Neurology 2004; 62:1199 - 1201; PMID: 15079026
   PubMed Web of Science ®Google Scholar
• Ballard C, Day S, Sharp S, Wing G, Sorensen S. Neuropsychiatric symptoms in dementia: importance and treatment considerations. Int Rev Psychiatry 2008; 20:396 - 404; PMID: 18925489; http://dx.doi.org/10.1080/09540260802099968
   PubMed Web of Science ®Google Scholar
• Borroni B, Costanzi C, Padovani A. Genetic susceptibility to behavioural and psychological symptoms in Alzheimer disease. Curr Alzheimer Res 2010; 7:158 - 164; PMID: 19715553; http://dx.doi.org/10.2174/156720510790691173
   PubMed Web of Science ®Google Scholar
• Flirski M, Sobow T, Kloszewska I. Behavioural genetics of Alzheimer's disease: a comprehensive review. Arch Med Sci 2011; 2:195 - 210; http://dx.doi.org/10.5114/aoms.2011.22068
   Web of Science ®Google Scholar
• Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993; 261:921 - 923; PMID: 8346443; http://dx.doi.org/10.1126/science.8346443
   PubMed Web of Science ®Google Scholar
• Kim J, Basak JM, Holtzman DM. The role of apolipoprotein E in Alzheimer's disease. Neuron 2009; 63:287 - 303; PMID: 19679070; http://dx.doi.org/10.1016/j.neuron.2009.06.026
   PubMed Web of Science ®Google Scholar
• Papassotiropoulos A, Lütjohann D, Bagli M, Locatelli S, Jessen F, Buschfort R, et al. 24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia. J Psychiatr Res 2002; 36:27 - 32; PMID: 11755458; http://dx.doi.org/10.1016/S0022-3956(01)00050-4
   PubMed Web of Science ®Google Scholar
• Garcia AN, Muniz MT, Souza e Silva HR, da Silva HA, Athayde-Junior L. Cyp46 polymorphisms in Alzheimer's disease: a review. J Mol Neurosci 2009; 39:342 - 345; PMID: 19705089; http://dx.doi.org/10.1007/s12031-009-9227-2
   PubMed Web of Science ®Google Scholar
• Golanska E, Hulas-Bigoszewska K, Wojcik I, Rieske P, Styczynska M, Peplonska B, et al. CYP46: a risk factor for Alzheimer's disease or a coincidence?. Neurosci Lett 2005; 383:105 - 108; PMID: 15936520; http://dx.doi.org/10.1016/j.neulet.2005.03.049
   PubMed Web of Science ®Google Scholar
• Palmer MS, Dryden AJ, Hughes JT, Collinge J. Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature 1991; 352:340 - 342; PMID: 1677164; http://dx.doi.org/10.1038/352340a0
   PubMed Web of Science ®Google Scholar
• Papassotiropoulos A, Wollmer MA, Aguzzi A, Hock C, Nitsch RM, de Quervain DJ. The prion gene is associated with human long-term memory. Hum Mol Genet 2005; 14:2241 - 2246; PMID: 15987701; http://dx.doi.org/10.1093/hmg/ddi228
   PubMed Web of Science ®Google Scholar
• Martorell L, Valero J, Mulet B, Gutiérrez-Zotes A, Cortés MJ, Jariod M, et al. M129V variation in the prion protein gene and psychotic disorders: relationship to neuropsychological and psychopathological measures. J Psychiatr Res 2007; 41:885 - 892; PMID: 16949098; http://dx.doi.org/10.1016/j.jpsychires.2006.07.003
   PubMed Web of Science ®Google Scholar
• Del Bo R, Scarlato M, Ghezzi S, Martinelli-Boneschi F, Fenoglio C, Galimberti G, et al. Is M129V of PRNP gene associated with Alzheimer's disease? A case-control study and a meta-analysis. Neurobiol Aging 2006; 27:7701 - 7705
   Web of Science ®Google Scholar
• Peoc'h K, Guérin C, Brandel JP, Launay JM, Laplanche JL. First report of polymorphisms in the prion-like protein gene (PRND): implications for human prion diseases. Neurosci Lett 2000; 286:144 - 148; PMID: 10825657; http://dx.doi.org/10.1016/S0304-3940(00)01100-9
   PubMedGoogle Scholar
• Mead S, Beck J, Dickinson A, Fisher EM, Collinge J. Examination of the human prion protein-like gene doppel for genetic susceptibility to sporadic and variant Creutzfeldt-Jakob disease. Neurosci Lett 2000; 290:117 - 120; PMID: 10936691; http://dx.doi.org/10.1016/S0304-3940(00)01319-7
   PubMed Web of Science ®Google Scholar
• Golanska E, Hulas-Bigoszewska K, Rutkiewicz E, Styczynska M, Peplonska B, Barcikowska M, et al. Polymorphisms within the prion (PrP) and prion-like protein (Doppel) genes in AD. Neurology 2004; 62:313 - 315; PMID: 14745079
   PubMed Web of Science ®Google Scholar
• Borroni B, Grassi M, Agosti C, Costanzi C, Archetti S, Franzoni S, et al. Genetic correlates of behavioral endophenotypes in Alzheimer disease: role of COMT, 5-HTTLPR and APOE polymorphisms. Neurobiol Aging 2006; 27:1595 - 603; PMID: 16257094; http://dx.doi.org/10.1016/j.neurobiolaging.2005.09.029
   PubMed Web of Science ®Google Scholar
• Pritchard AL, Harris J, Pritchard CW, Coates J, Haque S, Holder R, et al. The effect of the apolipoprotein E gene polymorphisms and haplotypes on behavioural and psychological symptoms in probable Alzheimer's disease. J Neurol Neurosurg Psychiatry 2007; 78:123 - 126; PMID: 16980336; http://dx.doi.org/10.1136/jnnp.2006.092122
   PubMed Web of Science ®Google Scholar
• Zdanys KF, Kleiman TG, MacAvoy MG, Black BT, Rightmer TE, Grey M, et al. Apolipoprotein E epsilon4 allele increases risk for psychotic symptoms in Alzheimer's disease. Neuropsychopharmacology 2007; 32:171 - 179; PMID: 16841077; http://dx.doi.org/10.1038/sj.npp.1301148
   PubMed Web of Science ®Google Scholar
• Holmes C, Russ C, Kirov G, Aitchison KJ, Powell JF, Collier DA, et al. Apolipoprotein E: depressive illness, depressive symptoms and Alzheimer's disease. Biol Psychiatry 1998; 43:159 - 164; PMID: 9494696; http://dx.doi.org/10.1016/S0006-3223(97)00326-0
   PubMed Web of Science ®Google Scholar
• Craig D, Hart DJ, Passmore AP. Genetically increased risk of sleep disruption in Alzheimer's disease. Sleep 2006; 29:1003 - 1007; PMID: 16944667
   PubMed Web of Science ®Google Scholar
• Yesavage JA, Friedman L, Kraemer H, Tinklenberg JR, Salehi A, Noda A, et al. Sleep/wake disruption in Alzheimer's disease: APOE status and longitudinal course. J Geriatr Psychiatry Neurol 2004; 17:20 - 24; PMID: 15018693; http://dx.doi.org/10.1177/0891988703261994
   PubMed Web of Science ®Google Scholar
• Stopa EG, Volicer L, Kuo-Leblanc V, Harper D, Lathi D, Tate B, et al. Pathologic evaluation of the human suprachiasmatic nucleus in severe dementia. J Neuropathol Exp Neurol 1999; 58:29 - 39; PMID: 10068311; http://dx.doi.org/10.1097/00005072-199901000-00004
   PubMed Web of Science ®Google Scholar
• Schröder B, Franz B, Hempfling P, Selbert M, Jürgens T, Kretzschmar HA, et al. Polymorphisms within the prion-like protein gene (Prnd) and their implications in human prion diseases, Alzheimer's disease and other neurological disorders. Hum Genet 2001; 109:319 - 325; PMID: 11702213; http://dx.doi.org/10.1007/s004390100591
   PubMed Web of Science ®Google Scholar
• Infante J, Llorca J, Rodero L, Palacio E, Berciano J, Combarros O. Polymorphism at codon 174 of the prion-like protein gene is not associated with sporadic Alzheimer's disease. Neurosci Lett 2002; 332:213 - 215; PMID: 12399017; http://dx.doi.org/10.1016/S0304-3940(02)00941-2
   PubMed Web of Science ®Google Scholar
• Ferrer I, Freixas M, Blanco R, Carmona M, Puig B. Selective PrP-like protein, doppel immunoreactivity in dystrophic neurites of senile plaques in Alzheimer's disease. Neuropathol Appl Neurobiol 2004; 30:329 - 337; PMID: 15305978; http://dx.doi.org/10.1111/j.1365-2990.2003.00534.x
   PubMed Web of Science ®Google Scholar
• Moore RC, Lee IY, Silverman GL, Harrison PM, Strome R, Heinrich C, et al. Ataxia in prion protein (PrP)-deficient mice is associated with upregulation of the novel PrP-like protein doppel. J Mol Biol 1999; 292:797 - 817; PMID: 10525406; http://dx.doi.org/10.1006/jmbi.1999.3108
   PubMed Web of Science ®Google Scholar
• McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34:939 - 944; PMID: 6610841
   PubMed Web of Science ®Google Scholar
• Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999; 56:303 - 308; PMID: 10190820; http://dx.doi.org/10.1001/archneur.56.3.303
   PubMed Web of Science ®Google Scholar
• Morris JC. Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type. Int Psychogeriatr 1997; 9:173 - 176; PMID: 9447441; http://dx.doi.org/10.1017/S1041610297004870
   PubMedGoogle Scholar
• Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189 - 198; PMID: 1202204; http://dx.doi.org/10.1016/0022-3956(75)90026-6
   PubMed Web of Science ®Google Scholar
• Cummings JL. The Neuropsychiatric Inventory: assessing psychopathology in dementia patients. Neurology 1997; 48:10 - 16; PMID: 9153155
   PubMed Web of Science ®Google Scholar
• Chapman J, Estupiñan J, Asherov A, Goldfarb LG. A simple and efficient method for apolipoprotein E genotype determination. Neurology 1996; 46:1484 - 1485; PMID: 8628509
   PubMed Web of Science ®Google Scholar
• Papassotiropoulos A, Streffer JR, Tsolaki M, Schmid S, Thal D, Nicosia F, et al. Increased brain beta-amyloid load, phosphorylated tau and risk of Alzheimer disease associated with an intronic CYP46 polymorphism. Arch Neurol 2003; 60:29 - 35; PMID: 12533085; http://dx.doi.org/10.1001/archneur.60.1.29
   PubMed Web of Science ®Google Scholar